Moreover, we found that TMBIM6 was up-regulated in bladder, lung, lymphoma, colorectal, and breast cancers, but specially increased in ductal or invasive breast carcinoma compared to in their normal tissue (Fig. 1c, Figure S1) 41-50. Here, TMBIM6 is linked to breast carcinoma.